ATA4812000A - Mittel zur behandlung von hepatitis c - Google Patents

Mittel zur behandlung von hepatitis c

Info

Publication number
ATA4812000A
ATA4812000A AT0048100A AT4812000A ATA4812000A AT A4812000 A ATA4812000 A AT A4812000A AT 0048100 A AT0048100 A AT 0048100A AT 4812000 A AT4812000 A AT 4812000A AT A4812000 A ATA4812000 A AT A4812000A
Authority
AT
Austria
Prior art keywords
agent
treating hepatitis
hepatitis
treating
Prior art date
Application number
AT0048100A
Other languages
English (en)
Other versions
AT408719B (de
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT0048100A priority Critical patent/AT408719B/de
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Priority to AU2001239000A priority patent/AU2001239000A1/en
Priority to JP2001568401A priority patent/JP2003527414A/ja
Priority to PCT/AT2001/000076 priority patent/WO2001070203A2/de
Priority to CA002389173A priority patent/CA2389173A1/en
Priority to PL01365000A priority patent/PL365000A1/xx
Priority to HR20020367A priority patent/HRP20020367A2/hr
Priority to EA200200584A priority patent/EA200200584A1/ru
Priority to MXPA02004993A priority patent/MXPA02004993A/es
Priority to IL14931401A priority patent/IL149314A0/xx
Priority to KR1020027005739A priority patent/KR20020087045A/ko
Priority to BR0107211-0A priority patent/BR0107211A/pt
Priority to CN01803046A priority patent/CN1416347A/zh
Publication of ATA4812000A publication Critical patent/ATA4812000A/de
Application granted granted Critical
Publication of AT408719B publication Critical patent/AT408719B/de
Priority to IS6360A priority patent/IS6360A/is
Priority to NO20022253A priority patent/NO20022253L/no
Priority to MA26657A priority patent/MA25509A1/fr
Priority to BG107088A priority patent/BG107088A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0048100A 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c AT408719B (de)

Priority Applications (17)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c
KR1020027005739A KR20020087045A (ko) 2000-03-22 2001-03-20 Ｃ형 간염 치료제
PCT/AT2001/000076 WO2001070203A2 (de) 2000-03-22 2001-03-20 Mittel zur behandlung von hepatitis c, enthaltend ukrain
CA002389173A CA2389173A1 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c
PL01365000A PL365000A1 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain
HR20020367A HRP20020367A2 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c
EA200200584A EA200200584A1 (ru) 2000-03-22 2001-03-20 Средство для лечения гепатита c
MXPA02004993A MXPA02004993A (es) 2000-03-22 2001-03-20 Medicamento para el tratramiento de hepatitis c.
AU2001239000A AU2001239000A1 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis C containing Ukrain
JP2001568401A JP2003527414A (ja) 2000-03-22 2001-03-20 Ｃ型肝炎を治療するための薬剤
BR0107211-0A BR0107211A (pt) 2000-03-22 2001-03-20 Agente para tratar hepatite c
CN01803046A CN1416347A (zh) 2000-03-22 2001-03-20 治疗丙肝的药剂
IL14931401A IL149314A0 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c
IS6360A IS6360A (is) 2000-03-22 2002-04-24 Lyf til meðhöndlunar á lifrarbólgu C
NO20022253A NO20022253L (no) 2000-03-22 2002-05-10 Middel til behandling av hepatitt C
MA26657A MA25509A1 (fr) 2000-03-22 2002-05-28 Composition destinee au traitement de l'hepatite c
BG107088A BG107088A (en) 2000-03-22 2002-09-12 Agent for treating hepatitis c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c

Publications (2)

Publication Number Publication Date
ATA4812000A true ATA4812000A (de) 2001-07-15
AT408719B AT408719B (de) 2002-02-25

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c

Country Status (17)

Country Link
JP (1) JP2003527414A (de)
KR (1) KR20020087045A (de)
CN (1) CN1416347A (de)
AT (1) AT408719B (de)
AU (1) AU2001239000A1 (de)
BG (1) BG107088A (de)
BR (1) BR0107211A (de)
CA (1) CA2389173A1 (de)
EA (1) EA200200584A1 (de)
HR (1) HRP20020367A2 (de)
IL (1) IL149314A0 (de)
IS (1) IS6360A (de)
MA (1) MA25509A1 (de)
MX (1) MXPA02004993A (de)
NO (1) NO20022253L (de)
PL (1) PL365000A1 (de)
WO (1) WO2001070203A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (de) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternäre Chelidonin- und Alkaloidderivate, Verfahren zu deren Herstellung und deren Verwendung in der Herstellung von Arzneimitteln
EP2083825A4 (de) * 2006-09-26 2009-11-04 Addiction Res Inst Inc Zusammensetzungen zur behandlung von hepatitis c und verfahren zur verwendung von zusammensetzungen zur behandlung von hepatitis c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
EA200200584A1 (ru) 2003-06-26
IL149314A0 (en) 2002-11-10
BR0107211A (pt) 2004-01-06
MA25509A1 (fr) 2002-07-01
BG107088A (en) 2003-05-30
WO2001070203A2 (de) 2001-09-27
JP2003527414A (ja) 2003-09-16
NO20022253D0 (no) 2002-05-10
AT408719B (de) 2002-02-25
CN1416347A (zh) 2003-05-07
HRP20020367A2 (en) 2004-02-29
NO20022253L (no) 2002-05-10
MXPA02004993A (es) 2003-10-14
PL365000A1 (en) 2004-12-27
IS6360A (is) 2002-04-24
KR20020087045A (ko) 2002-11-21
WO2001070203A3 (de) 2002-09-06
AU2001239000A1 (en) 2001-10-03
CA2389173A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
DE60020171D1 (de) Gerät zur behandlung von bandscheiben
DE60001421D1 (de) Behandlung von abgas
DE60117977D1 (de) Vorrichtungen zur behandlung von harninkontinenz
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
ATE426373T1 (de) Apparat zur behandlung von zahnen
ATE318138T1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE60227095D1 (de) Zusammensetzungen und verfahren zur behandlung von abgebundenem gips
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60132089D1 (de) Vorrichtung zur behandlung von gasen miitels plasma
EP1324780A4 (de) Methoden zur behandlung von herzarrhythmie
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE473944T1 (de) Mittel zur wasserbehandlung
DE60103137D1 (de) Impstoff zur behandlung von atherosclerosis
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60012138D1 (de) Gerät zur behandlung von fibrillation
DE60014928D1 (de) Retinoide zur behandlung von emphysem
ATE301266T1 (de) Vorrichtung zur behandlung von abfällen
DE60033020D1 (de) Gerät zur behandlung von zahnkaries
EP1117431A4 (de) Behandlung von acidose
ATE298569T1 (de) Virus behandlung
DE60224650D1 (de) Vorrichtung zur behandlung von vorhof-fibrillation
DE60133996D1 (de) Kosmetisches VERFAHREN ZUR BEHANDLUNG VON Celluliten
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee